IRIS
TERRANOVA, NADIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 706
EU - Europa 484
AS - Asia 401
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 2
OC - Oceania 1
SA - Sud America 1
Totale 1.599
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 698
CN - Cina 349
IE - Irlanda 184
UA - Ucraina 80
DE - Germania 52
FI - Finlandia 51
SE - Svezia 42
SG - Singapore 42
IT - Italia 32
GB - Regno Unito 17
BE - Belgio 15
CA - Canada 8
FR - Francia 5
EU - Europa 4
GR - Grecia 4
KR - Corea 3
IL - Israele 2
JP - Giappone 2
MU - Mauritius 2
AU - Australia 1
BO - Bolivia 1
CH - Svizzera 1
HK - Hong Kong 1
IN - India 1
KZ - Kazakistan 1
NL - Olanda 1
Totale 1.599
Salva come PNG Salva come JPEG
Città #
Dublin 182
Chandler 166
Jacksonville 113
Nanjing 93
Ann Arbor 52
Beijing 52
Boardman 50
Nanchang 41
Singapore 36
Ashburn 32
Hebei 29
Princeton 26
Lawrence 25
Medford 25
Wilmington 24
Changsha 22
Shenyang 21
Jiaxing 20
Tianjin 19
Dearborn 18
New York 18
Shanghai 18
Pavia 17
Hangzhou 16
Brussels 15
Helsinki 10
Woodbridge 8
Toronto 7
Los Angeles 5
Kunming 4
Milan 4
Norwalk 4
Fairfield 3
Ningbo 3
Piscataway 3
Washington 3
Hefei 2
Houston 2
Netanya 2
Saronno 2
Tokyo 2
Zhengzhou 2
Amsterdam 1
Carate Brianza 1
Cincinnati 1
Des Moines 1
Fuzhou 1
Grugliasco 1
Guangzhou 1
Gunzenhausen 1
Hong Kong 1
Hyderabad 1
Lanzhou 1
Las Vegas 1
Lausanne 1
Lodi Vecchio 1
Newark 1
Orange 1
Redwood City 1
Santa Clara 1
Seattle 1
Secaucus 1
Springfield 1
Sucre 1
Sydney 1
Taizhou 1
Verona 1
Totale 1.221
Salva come PNG Salva come JPEG
Nome #
A non parametric population approach for selecting biomarkers of a drug action 99
A mathematical model for assessing the glucose time course in critically ill patients 91
An energy based model able to describe the effect of anticancer drugs on tumor growth and host body weight 89
A data mining approach to evaluate the performance of recruitment centres in antidepressant drug clinical trials 87
A PK-PD model of tumor growth after administration of an anti-angiogenic agent given alone or in combination therapies in xenograft mice 84
A new population PK/PD model to assess the myelotoxicity of candidate drugs in preclinical and in clinical studies 78
A predictive pharmacokinetic-pharmacodynamic model of tumor growth kinetics in xenograft mice after administration of anticancer agents given in combination 78
Mathematical models of tumor growth inhibition in xenograft mice after administration of anticancer agents given in combination 74
A tumor growth inhibition model in drugs combination regimens 71
A Minimal Model of Tumor Growth Inhibition in Combination Regimens under the Hypothesis of no Interaction between Drugs 71
Study of energetic interactions between the tumor and host to assess the efficacy of an anticancer drug: a new mathematical model 71
Modelling of protozoa dynamics and drug effects in a murine model of malaria infection 66
Mouse embryonic stem cells that survive γ-rays exposure maintain pluripotent differentiation potential and genome stability. 64
Landscape on technical and conceptual requirements in Drug/Disease Modelling & Simulation 61
Modeling tumor growth inhibition and toxicity outcome after administration of anticancer agents in xenograft mice: A Dynamic Energy Budget (DEB) approach 59
Mathematical modeling of growth and death dynamics of mouse embryonic stem cells irradiated with gamma-rays 56
Assessing the glucose time course in critically ill patients by a mathematical model 56
TGI-Simulator: A visual tool to support the preclinical phase of the drug discovery process by assessing in silico the effect of an anticancer drug 52
Evaluation of a PK/PD DEB-based model for tumor-in-host growth kinetics under anticancer treatment 49
Evaluation of a tumor growth inhibition (TGI) model integrating dynamic energy budget (DEB) theory 47
Model description language (MDL): a standard for pharmacometric modelling and simulation 45
Model Description Language (MDL) - a standard for model communication and interoperability 45
Quantitative evaluation of the Aurora inhibition effect on gene and protein expression: a mathematical modelling approach 41
White Paper: Landscape on Technical and Conceptual Requirements and Competence Framework in Drug/Disease Modeling and Simulation 39
A translational model-based approach to inform the choice of the dose in phase 1 oncology trials: the case study of erdafitinib 34
Combining Reinforcement Learning and PK-PD models to personalize multiple drug administration: an application to Axitinib-Anti-Hypertensive treatment in metastatic renal cancer patients 20
Totale 1.627
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.859
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.859
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020129 0 0 0 0 1 20 10 29 9 37 23 0
2020/2021183 19 17 6 20 2 21 3 29 7 26 27 6
2021/2022134 5 4 6 1 4 1 3 10 9 5 19 67
2022/2023479 52 52 4 33 49 38 1 26 194 4 11 15
2023/2024133 10 12 10 16 7 39 0 10 1 5 7 16
2024/202594 5 34 12 21 22 0 0 0 0 0 0 0
Totale 1.627